Sinopharm Group Co. Ltd. (OTCMKTS:SHTDY – Get Free Report) was the recipient of a significant growth in short interest in the month of July. As of July 15th, there was short interest totaling 80,000 shares, a growth of 72.5% from the June 30th total of 46,379 shares. Based on an average daily volume of 290,834 shares, the short-interest ratio is presently 0.3 days.
Sinopharm Group Stock Down 1.0%
Shares of Sinopharm Group stock opened at $11.07 on Friday. The business has a 50-day simple moving average of $10.78 and a 200 day simple moving average of $12.21. Sinopharm Group has a one year low of $10.00 and a one year high of $14.87.
About Sinopharm Group
Sinopharm Group Co, Ltd. (OTCMKTS:SHTDY) is one of China’s largest integrated healthcare companies and an indirect subsidiary of the state-owned China National Pharmaceutical Group Co, Ltd. The company operates through two primary segments—pharmaceutical distribution and retail pharmacy—offering comprehensive supply chain solutions that span procurement, storage, transportation and sales of medical products. With a broad portfolio that includes prescription drugs, over-the counter medicines, medical devices and consumables, Sinopharm serves hospitals, clinics, retail pharmacies and other healthcare institutions across mainland China.
In its distribution business, Sinopharm leverages an extensive logistics network, comprising hundreds of distribution centers and thousands of delivery vehicles, to ensure timely delivery of pharmaceuticals under stringent temperature-controlled conditions.
Featured Stories
- Five stocks we like better than Sinopharm Group
- Chevron’s Strong Quarter Shows Why It Still Leads the Energy Sector
- Amazon’s Earnings Beat Shows Why AWS Is Back at the Center of the Bull Case
- Apple’s Record Quarter Could Not Outrun Its Guidance Problem
- McKesson’s Compounding Keeps Adding Up
Receive News & Ratings for Sinopharm Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sinopharm Group and related companies with MarketBeat.com's FREE daily email newsletter.
